Skip to content

Bruker BRKR Price / earnings

Price / earnings at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
26.7×-2.2×
Danaher logo
DanaherDHR
36.4×-2.6×
TEC
Bio-TechneTECH
70.4×+15.8×
WAT
Waters CorporationWAT
65×+31.7×
Agilent Technologies logo
Agilent TechnologiesA
23.1×-3.1×
Revvity logo
RevvityRVTY
40.9×-3.5×

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Calculated from Bruker’s reported figures.

Based on the most recent quarter.

The official record: Bruker’s 10-Q, filed August 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Bruker's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's price / earnings?
Bruker (BRKR) reported price / earnings of 75.5× in Q2 2025.
How has Bruker's price / earnings changed year-over-year?
Bruker's price / earnings increased by 175.3% year-over-year, from 27.4× to 75.5×.
What is the long-term trend for Bruker's price / earnings?
Over 4 years (2020 to 2024), Bruker's price / earnings has grown at a 10.9% compound annual growth rate (CAGR), from 52× to 78.6×.
What does price / earnings mean?
How many dollars investors pay for each dollar of the company's annual profit.
How do you interpret price / earnings?
Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
How does price / earnings compare across companies?
Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.